Patent Assignment
Reel/Frame 033600/0553
Assignment of Assignor's Interest
Recorded: 2014-08-25
Pages: 5
Assignor
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.
Executed: 2014-06-20
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Property
(1)
CANCER PATIENT SELECTION FOR ADMINISTRATION OF Wnt SIGNALING INHIBITORS USING RNF43 MUTATION STATUS
Application:
14/380,776 →
Publication:
US 2015/0125857
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 25, 2014
From: CONG, FENG; HAO, HUAIXIANG; JIANG, XIAOMO
To: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.
Reel/Frame 033600/0528 →
Assignment of Assignor's Interest
Aug 25, 2014
From: HSIEH, MINDY HSIN-I; LIU, JUN; NG, NICHOLAS
To: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS INC.
Reel/Frame 033600/0581 →
Assignment of Assignor's Interest
Aug 25, 2014
From: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS INC.
To: IRM LLC
Reel/Frame 033600/0699 →
Assignment of Assignor's Interest
May 14, 2015
From: NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
To: NOVARTIS AG
Reel/Frame 035635/0829 →
Merger and Change of Name
Jan 27, 2016
From: IRM LLC; NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.; NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
To: NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
Reel/Frame 037599/0484 →